Bicara Therapeutics (BCAX) Selling, General & Administrative (2023 - 2026)
Bicara Therapeutics (BCAX) recorded Selling, General & Administrative of $14.18 million in Q2 2026, up 96.4% from $7.22 million a year earlier and up 11.3% from the prior quarter.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Selling, General & Administrative (2023 - 2026) Analysis & Trends
On a TTM basis, Bicara Therapeutics' Selling, General & Administrative came in at $42.75 million as of Jun 30, 2026, up 63.2% year-over-year; for FY2025, it was $30.51 million, up 62.5% from FY2024.
- Across earlier years, Selling, General & Administrative came in at $18.77 million in FY2024 (+102.4%) and $9.27 million in FY2023.
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q3 2023.
- On a year-over-year basis, Selling, General & Administrative has increased for eight consecutive quarters, with growth averaging 82.1% over the last eight quarters.
- The year-over-year growth in Selling, General & Administrative has ranged between 20.4% (Q4 2025) and 123.1% (Q1 2025) over the last five years.
- Per Business Quant, the preceding three quarters came in at $12.74 million (Q1 2026), $8.13 million (Q4 2025) and $7.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Bicara Therapeutics | 1.20 Bn | 1.20 Bn | - | 14.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.18 Mn |
| Mar 31, 2026 | 12.74 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Mar 31, 2025 | 7.46 Mn |
| Dec 31, 2024 | 6.75 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 2.59 Mn |
API Access
Bicara Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BCAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BCAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();